The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Accuretic 20 mg/12.5 mg film-coated tablets



Pfizer Healthcare IrelandPA0822/008/002

Main Information

Trade NameAccuretic 20 mg/12.5 mg film-coated tablets
Active SubstancesQuinagolide hydrochloride
Hydrochlorothiazide
Dosage FormFilm-coated tablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/008/002

Group Information

ATC CodeC09BA ACE inhibitors and diuretics
C09BA06 quinapril and diuretics

Status

License statusWithdrawn
Withdrawn Date11/09/2024
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back